Charles Clift

604 total citations
26 papers, 227 citations indexed

About

Charles Clift is a scholar working on Economics and Econometrics, Applied Microbiology and Biotechnology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Charles Clift has authored 26 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Economics and Econometrics, 5 papers in Applied Microbiology and Biotechnology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Charles Clift's work include Pharmaceutical Economics and Policy (6 papers), Antibiotic Use and Resistance (5 papers) and Pneumonia and Respiratory Infections (2 papers). Charles Clift is often cited by papers focused on Pharmaceutical Economics and Policy (6 papers), Antibiotic Use and Resistance (5 papers) and Pneumonia and Respiratory Infections (2 papers). Charles Clift collaborates with scholars based in United Kingdom, United States and Norway. Charles Clift's co-authors include David Salisbury, John‐Arne Røttingen, Kevin Outterson, Unni Gopinathan, Chantal Morel, Anthony D. So, John-Arne Røttingen, Kai Schulze, Michael Anderson and Elías Mossialos and has published in prestigious journals such as The Lancet, BMJ and PLoS Medicine.

In The Last Decade

Charles Clift

26 papers receiving 210 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles Clift United Kingdom	9	72	60	36	26	22	26	227
Mohammed Seid Hussen Ethiopia	12	49 0.7×	74 1.2×	25 0.7×	75 2.9×	24 1.1×	30	395
Nicholas Stine United States	6	39 0.5×	68 1.1×	78 2.2×	35 1.3×	17 0.8×	13	265
Wolfgang Hein Germany	11	57 0.8×	59 1.0×	28 0.8×	14 0.5×	26 1.2×	50	414
Victoria L. Simpkin United Kingdom	5	41 0.6×	33 0.6×	45 1.3×	40 1.5×	33 1.5×	6	275
Genevie Fernandes United Kingdom	9	43 0.6×	30 0.5×	23 0.6×	22 0.8×	32 1.5×	20	301
Grace Biyinzika Lubega Uganda	7	69 1.0×	19 0.3×	52 1.4×	15 0.6×	15 0.7×	22	207
Nicolas Levrat Switzerland	5	90 1.3×	19 0.3×	66 1.8×	15 0.6×	14 0.6×	37	235
Germán Velásquez Switzerland	9	62 0.9×	160 2.7×	28 0.8×	18 0.7×	23 1.0×	25	378
Nelson Ashinedu Ukor United Kingdom	5	79 1.1×	34 0.6×	29 0.8×	40 1.5×	79 3.6×	5	309
Xiaoxi Zhang China	10	23 0.3×	92 1.5×	28 0.8×	23 0.9×	58 2.6×	32	507

Countries citing papers authored by Charles Clift

Since Specialization

Citations

This map shows the geographic impact of Charles Clift's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Clift with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Clift more than expected).

Fields of papers citing papers by Charles Clift

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Clift. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Clift. The network helps show where Charles Clift may publish in the future.

Co-authorship network of co-authors of Charles Clift

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Clift. A scholar is included among the top collaborators of Charles Clift based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Clift. Charles Clift is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anderson, Michael, et al.. (2019). Averting the AMR crisis: What are the avenues for policy action for countries in Europe?. Europe PMC (PubMed Central). 26 indexed citations

Clift, Charles. (2019). Review of Progress on Antimicrobial Resistance. 4 indexed citations

Clift, Charles & John‐Arne Røttingen. (2018). New approaches to WHO financing: the key to better health. BMJ. 361. k2218–k2218. 7 indexed citations

Clift, Charles & David Salisbury. (2017). Enhancing the role of vaccines in combatting antimicrobial resistance. Vaccine. 35(48). 6591–6593. 25 indexed citations

Outterson, Kevin, Unni Gopinathan, Charles Clift, et al.. (2016). Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality. PLoS Medicine. 13(6). e1002043–e1002043. 35 indexed citations

Balasegaram, Manica, Charles Clift, & John‐Arne Røttingen. (2015). The Global Innovation Model for Antibiotics Needs Reinvention. The Journal of Law Medicine & Ethics. 43(S3). 22–26. 9 indexed citations

Clift, Charles. (2015). What's the World Health Organization For?. 6 indexed citations

Clift, Charles, Unni Gopinathan, Chantal Morel, et al.. (2015). Towards a new global business model for antibiotics: delinking revenues from sales.. London School of Economics and Political Science Research Online (London School of Economics and Political Science). 15 indexed citations

Clift, Charles. (2013). The Role of the World Health Organization in the International System. 14 indexed citations

10.

Hargreaves, James, Brian Greenwood, Charles Clift, et al.. (2011). Making new vaccines affordable: a comparison of financing processes used to develop and deploy new meningococcal and pneumococcal conjugate vaccines. The Lancet. 378(9806). 1885–1893. 22 indexed citations

11.

Clift, Charles. (2008). The Value of Patent Term Extensions to the Pharmaceutical Industry in the USA. Journal of Generic Medicines The Business Journal for the Generic Medicines Sector. 5(3). 201–208. 8 indexed citations

12.

Clift, Charles, A. Krattiger, R. T. Mahoney, et al.. (2007). Data protection and data exclusivity in pharmaceuticals and agrochemicals.. 431–435. 5 indexed citations

13.

Clift, Charles. (2007). Patenting and Licensing Research Tools. 79–88. 2 indexed citations

14.

Clift, Charles. (1999). East Asia Crisis Seminar: Summary of Discussion. IDS Bulletin. 30(1). 14–18. 1 indexed citations

15.

Clift, Charles. (1988). Aid Co‐ordination: Are There Any Lessons to be Learnt from Kenya?. Development Policy Review. 6(2). 115–137. 10 indexed citations

16.

Clift, Charles, et al.. (1984). Broadcast public files: FCC requirements, station performance and public use. Journal of Broadcasting. 28(3). 305–313. 2 indexed citations

17.

Eastman, Susan Tyler, Sydney W. Head, Charles Clift, et al.. (1981). Broadcast Programming. Communication Booknotes. 12(2). 24–25. 5 indexed citations

18.

Healey, John & Charles Clift. (1980). The Developmental Rationale for Aid Re-examined. Development Policy Review. A13(2). 14–34. 2 indexed citations

19.

Clift, Charles, et al.. (1971). Ten years of forfeitures by the federal communications commission. Journal of Broadcasting. 15(4). 379–386. 3 indexed citations

20.

Clift, Charles, et al.. (1970). Station license revocations and denials of renewal, 1934–1969. Journal of Broadcasting. 14(4). 411–421. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact